Search results
Results from the WOW.Com Content Network
The law has an ongoing impact and is still referenced as a resource for patient rights. While the 1998 Act was hugely significant, there is a proposed amendment to this act circulating in the State of California, calling for greater control over treatment implementation by women, coverage by board-certified surgeons who are breast specialists ...
(Reuters) -A U.S. appeals court on Friday refused to block a federal mandate requiring health insurers to cover preventive care services like cancer screenings and HIV-preventing medication at no ...
Opinion: Medicare must provide immediate coverage for new preventive care tools and services for treating cancer. Medicare must fund blood-based cancer screenings. NY's delegatin must act
The National Quality Cancer Care Demonstration Project Act of 2009 (H.R. 3675 IH) is an initiative intended to enhance the quality of cancer care in the United States, focused on seniors covered by Medicare (approximately 45% of cancer patients are Medicare beneficiaries), while also controlling costs.
The objective of cancer screening is to detect cancer before symptoms appear, involving various methods such as blood tests, urine tests, DNA tests, and medical imaging. [ 1 ] [ 2 ] The purpose of screening is early cancer detection, to make the cancer easier to treat and extending life expectancy. [ 3 ]
Medicare covers cancer treatment and many of the related expenses of cancer care for prostate cancer and other types of cancer. Different parts of Medicare may cover various aspects of your care.
MammaPrint is a prognostic and predictive diagnostic test for early stage breast cancer patients that assess the risk that a tumor will metastasize to other parts of the body. [1] It gives a binary result, high-risk or low-risk classification , and helps physicians determine whether or not a patient will benefit from chemotherapy .
Acquired and inherited cancer: Medicare may cover next generation sequencing, a type of genetic test that can diagnose or assess a person’s level of risk for various cancers.